ISRG ROE | Intuitive Surgical, Inc.

INTUITIVE SURGICAL INC ROE

Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

INTUITIVE SURGICAL INC roe for the quarter ending 2026-06-30 was 17.28%, a 18.23% increase year-over-year.
INTUITIVE SURGICAL INC roe for the quarter ending 2026-03-31 was 17.05%, a 17.78% increase year-over-year.
INTUITIVE SURGICAL INC roe for the quarter ending 2025-12-31 was 16.02%, a 13.37% increase year-over-year.
INTUITIVE SURGICAL INC roe for the quarter ending 2025-09-30 was 16.23%, a 12.72% increase year-over-year.
INTUITIVE SURGICAL INC roe for fiscal 2025 was 16.02%, a 13.37% increase from fiscal 2024.
INTUITIVE SURGICAL INC roe for fiscal 2024 was 14.13%, a 4.60% increase from fiscal 2023.
INTUITIVE SURGICAL INC roe for fiscal 2023 was 13.51%, a 12.82% increase from fiscal 2022.
INTUITIVE SURGICAL INC roe for fiscal 2022 was 11.98%, a 16.39% decline from fiscal 2021.

Available history: 2007-12-31 to 2026-06-30
Data captured: 2026-06-30

Historical ROE

Date	ROE	Net income 12 month	Net income 3 month	Shareholder equity
2026-06-30	17.28%	$3.14B	$818.10M	$18.17B
2026-03-31	17.05%	$2.98B	$821.50M	$17.47B
2025-12-31	16.02%	$2.86B	$794.80M	$17.82B
2025-09-30	16.23%	$2.75B	$704.40M	$16.93B
2025-06-30	14.61%	$2.61B	$658.40M	$17.85B
2025-03-31	14.47%	$2.48B	$698.40M	$17.11B
2024-12-31	14.13%	$2.32B	$685.70M	$16.43B
2024-09-30	14.39%	$2.24B	$565.10M	$15.58B
2024-06-30	14.23%	$2.09B	$526.90M	$14.71B
2024-03-31	14.24%	$1.99B	$544.90M	$13.96B
2023-12-31	13.51%	$1.8B	$606.20M	$13.31B
2023-09-30	12.10%	$1.52B	$415.70M	$12.54B
2023-06-30	12.00%	$1.43B	$420.80M	$11.88B
2023-03-31	11.70%	$1.31B	$355.30M	$11.22B
2022-12-31	11.98%	$1.32B	$324.90M	$11.04B
2022-09-30	11.97%	$1.38B	$324.00M	$11.52B
2022-06-30	11.93%	$1.43B	$307.80M	$12.02B
2022-03-31	13.58%	$1.64B	$365.60M	$12.1B
2021-12-31	14.32%	$1.7B	$380.60M	$11.9B
2021-09-30	14.80%	$1.69B	$380.50M	$11.41B
2021-06-30	14.97%	$1.62B	$517.20M	$10.84B
2021-03-31	11.56%	$1.17B	$426.30M	$10.15B
2020-12-31	10.90%	$1.06B	$365.20M	$9.73B
2020-09-30	11.38%	$1.05B	$313.90M	$9.26B
2020-06-30	13.00%	$1.14B	$68.00M	$8.74B
2020-03-31	16.30%	$1.39B	$313.50M	$8.51B
2019-12-31	16.69%	$1.38B	$357.70M	$8.26B
2019-09-30	16.93%	$1.31B	$396.80M	$7.76B
2019-06-30	16.65%	$1.21B	$318.30M	$7.27B
2019-03-31	16.33%	$1.15B	$306.50M	$7.02B
2018-12-31	16.89%	$1.13B	$292.50M	$6.68B
2018-09-30	12.80%	$803.9M	$292.50M	$6.28B
2018-06-30	13.82%	$810M	$255.30M	$5.86B
2018-03-31	14.15%	$777.7M	$287.60M	$5.5B
2017-12-31	14.04%	$670.9M	-$31.50M	$4.78B
2017-09-30	18.33%	$908.8M	$298.60M	$4.96B
2017-06-30	18.16%	$821.2M	$223.00M	$4.52B
2017-03-31	18.96%	$782.7M	$180.80M	$4.13B
2016-12-31	12.78%	$738.3M	$204.00M	$5.78B
2016-09-30	13.03%	$721.9M	$211.00M	$5.54B
2016-06-30	13.09%	$678.2M	$184.50M	$5.18B
2016-03-31	13.22%	$628.2M	$136.40M	$4.75B
2015-12-31	13.63%	$588.8M	$190.00M	$4.32B
2015-09-30	13.26%	$545.6M	$167.30M	$4.12B
2015-06-30	13.24%	$502M	$134.50M	$3.79B
2015-03-31	13.15%	$471.5M	$97.00M	$3.59B
2014-12-31	12.39%	$418.8M	$146.80M	$3.38B
2014-09-30	14.21%	$438.2M	$123.70M	$3.08B
2014-06-30	16.70%	$471.3M	$104.00M	$2.82B
2014-03-31	14.40%	$526.4M	$44.30M	$3.66B
2013-12-31	19.16%	$671M	$166.20M	$3.5B
2013-09-30	20.82%	$679.7M	$156.80M	$3.26B
2013-06-30	18.99%	$706.2M	$159.10M	$3.72B
2013-03-31	18.61%	$702M	$188.90M	$3.77B
2012-12-31	18.34%	$656.6M	$174.90M	$3.58B
2012-09-30	19.22%	$632.9M	$183.30M	$3.29B
2012-06-30	17.97%	$572M	$154.90M	$3.18B
2012-03-31	18.26%	$534.5M	$143.50M	$2.93B
2011-12-31	18.71%	$495.1M	$151.20M	$2.65B
2011-09-30	19.63%	$465.1M	$122.40M	$2.37B
2011-06-30	18.76%	$429.3M	$117.40M	$2.29B
2011-03-31	17.96%	$400.6M	$104.10M	$2.23B
2010-12-31	18.74%	$381.8M	$121.20M	$2.04B
2010-09-30	16.84%	$338.2M	$86.60M	$2.01B
2010-06-30	16.43%	$316.1M	$88.70M	$1.92B
2010-03-31	16.37%	$289.8M	$85.30M	$1.77B
2009-12-31	15.13%	$232.6M	$77.50M	$1.54B
2009-09-30	14.80%	$205.74M	$64.60M	$1.39B
2009-06-30	15.64%	$198.84M	$62.40M	$1.27B

Annual ROE

Date	ROE	Net income 12 month	Shareholder equity
2025-12-31	16.02%	$2.86B	$17.82B
2024-12-31	14.13%	$2.32B	$16.43B
2023-12-31	13.51%	$1.8B	$13.31B
2022-12-31	11.98%	$1.32B	$11.04B
2021-12-31	14.32%	$1.7B	$11.9B
2020-12-31	10.90%	$1.06B	$9.73B
2019-12-31	16.69%	$1.38B	$8.26B
2018-12-31	16.89%	$1.13B	$6.68B
2017-12-31	14.04%	$670.9M	$4.78B
2016-12-31	12.78%	$738.3M	$5.78B
2015-12-31	13.63%	$588.8M	$4.32B
2014-12-31	12.39%	$418.8M	$3.38B
2013-12-31	19.16%	$671M	$3.5B
2012-12-31	18.34%	$656.6M	$3.58B
2011-12-31	18.71%	$495.1M	$2.65B
2010-12-31	18.74%	$381.8M	$2.04B
2009-12-31	15.13%	$232.6M	$1.54B
2008-12-31	16.13%	$204.3M	$1.27B
2007-12-31	16.26%	$144.54M	$888.7M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Edwards Lifesciences Corp (EW)	United States	$49.409B	51.96
STERIS plc (STE)	Ireland	$20.343B	25.49
ZIMMER BIOMET HOLDINGS, INC. (ZBH)	United States	$17.103B	20.66
ALIGN TECHNOLOGY INC (ALGN)	United States	$10.346B	29.06
MSA Safety Inc (MSA)	United States	$7.023B	21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)		$1.954B	-65.76
Cadre Holdings, Inc. (CDRE)	United States	$1.123B	33.88
Enovis CORP (ENOV)	United States	$1.053B	-1.18
Anteris Technologies Global Corp. (AVR)	United States	$0.746B
Sanara MedTech Inc. (SMTI)	United States	$0.323B	-6.81